News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
289 Results
Type
Article (15)
Press Release (274)
Section
Business (66)
Deals (12)
Drug Development (92)
FDA (13)
Job Trends (41)
News (172)
Policy (17)
Tag
Alliances (15)
Approvals (12)
Best Places to Work (40)
Cancer (1)
Clinical research (61)
COVID-19 (5)
Data (1)
Diagnostics (5)
Earnings (31)
Events (71)
FDA (13)
Government (6)
Healthcare (6)
Infectious disease (5)
IPO (11)
Job creations (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2025 (6)
Pancreatic cancer (1)
Patents (1)
People (16)
Phase I (47)
Phase II (37)
Phase III (11)
Pipeline (1)
Preclinical (17)
Real estate (1)
Regulatory (14)
Research institute (4)
Startups (1)
Vaccines (2)
Date
Last 7 days (3)
Last 30 days (5)
Last 365 days (15)
2025 (8)
2024 (23)
2023 (34)
2022 (42)
2021 (31)
2020 (71)
2019 (33)
2018 (10)
2017 (22)
2016 (14)
2013 (1)
Location
Asia (1)
Europe (3)
Texas (9)
United States (9)
289 Results for "moleculin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin
May 7, 2025
·
6 min read
Press Releases
Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents
May 5, 2025
·
5 min read
Press Releases
Moleculin to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call and Webcast
May 7, 2025
·
4 min read
Press Releases
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
April 1, 2025
·
6 min read
Press Releases
Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer
April 30, 2025
·
6 min read
Press Releases
Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 17, 2025
·
4 min read
Press Releases
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
March 25, 2025
·
11 min read
Press Releases
Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast
March 19, 2025
·
2 min read
Lone Star Bio
Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity
Moleculin Biotech, Inc. announced that it will present at the Virtual Investor Lunch Break: The Moleculin Opportunity event on Thursday, March 28, 2024 at 12:00 PM ET.
March 27, 2024
·
2 min read
Lone Star Bio
Moleculin to Present at the Virtual Investor Pitch Conference - June 12, 2024
Moleculin Biotech, Inc. announced that it will present at the Virtual Investor Pitch Conference on June 18, 2024 at 3:00 PM ET.
June 12, 2024
·
2 min read
1 of 29
Next
